To determine the role of ST6GalNAc‐I in mucin glycosylation and its role in cancer cell aggressiveness, we performed CRISPR‐Cas9‐based KO of ST6GalNAc‐I in A549 and H1437 cells. This evidence concerns the gene MUC5AC and cancer.